| # | Drug | Count |
|---|---|---|
| 0 | CARBOPLATIN | 12 |
| 1 | AMITRIPTYLINE HYDROCHLORIDE | 11 |
| 2 | BEVACIZUMAB | 11 |
| 3 | ESOMEPRAZOLE | 11 |
| 4 | ESOMEPRAZOLE MAGNESIUM | 11 |
| 5 | GEMCITABINE HYDROCHLORIDE | 11 |
| 6 | HYDROXYCHLOROQUINE SULFATE | 11 |
| 7 | OLAPARIB | 11 |
| 8 | PACLITAXEL | 11 |
| 9 | GEMCITABINE | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ETOPOSIDE PHOSPHATE | 2 | 0.0012 |
| 1 | AMITRIPTYLINE HYDROCHLORIDE | 11 | 0.0006 |
| 2 | OLAPARIB | 11 | 0.0005 |
| 3 | SOTALOL HYDROCHLORIDE TABLES AF | 1 | 0.0004 |
| 4 | SOTALOL HYDROCHLORIDE TABLETS AF | 1 | 0.0004 |
| 5 | GEMCITABINE HYDROCHLORIDE | 11 | 0.0002 |
| 6 | ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE | 1 | 0.0001 |
| 7 | FOSAPREPITANT DIMEGLUMINE | 2 | 0.0001 |
| 8 | HYDROXYCHLOROQUINE SULFATE | 11 | 0.0001 |
| 9 | PACLITAXEL | 11 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 11 | 0.0005 |
| 1 | Microtubule Inhibitor [EPC] | 11 | 0.0001 |
| 2 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 11 | 0.0001 |
| 3 | Platinum-based Drug [EPC] | 13 | 0.0000 |
| 4 | Proton Pump Inhibitor [EPC] | 11 | 0.0000 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 5 | 0.0000 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 4 | 0.0000 |
| 7 | Topoisomerase Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Alkylating Drug [EPC] | 3 | 0.0000 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 5 | 0.0000 |